EUVIMEDEUVIMED entdecken
Crossref

CDK16 + Luminal Progenitor Cell‐Like Tumor Cells Interacted with POSTN + Cancer‐Associated Fibroblasts Associate with Chemo‐Resistance In Breast Cancer

Xinyu Ding iD, Qi Wu iD, Yanhua Du iD, Meng-Meng Ji iD, Hua Yang iD, Qingsong Hu iD, Youqiong Ye iD

Small Methods · 2025

DOI: 10.1002/smtd.202401192 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small Methods, 2025. Verfasst von Xinyu Ding und 6 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Institute of Immunology, Center for Immune-Related Diseases Research at Ruijin Hospital affiliated to Shanghai Jiao Tong University School o…. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Breast Neoplasms, Cancer-Associated Fibroblasts, Neoplastic Stem Cells. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shanghai Municipality, Shanghai Jiao Tong University 2030 Initiative.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor heterogeneity and interaction with tumor microenvironment play a crucial role in neoadjuvant chemotherapy (NAC) resistance in breast cancer (BRCA). Unraveling this dynamic interaction may help uncover novel therapeutic targets. Here, dynamic changes in tumor states and cellular composition are systemically characterized using 175,825 single‐cell transcriptomics from naïve and post‐treatment biopsies of BRCA patients receiving NAC. CDK16 + tumors are identified featured with luminal progenitor cell (LPC)‐like tumor cells enriched in the triple‐negative subtype of BRCA, associated with chemo‐resistance. Integrating single‐cell RNA sequencing (scRNA‐seq), spatial transcriptomics, and six independent public gene expression profiles that underwent chemotherapy revealed that POSTN + cancer‐associated fibroblasts (CAFs) are closely localized and interacted with CDK16 + LPC‐like tumor cells to promote chemo‐resistance. In vivo, CDK16 knockdown in tumor cells combined with chemotherapy significantly enhanced therapeutic efficacy. This in‐house scRNA‐seq from a mouse model validated that CDK16 knockdown reduced the LPC‐like tumor cell signature, and the interaction of tumor featured with LPC‐like tumor cells and POSTN + CAFs. Together, the systematically integrated analyses uncovered an interaction network of CDK16 + tumor and POSTN + CAFs that contributed to NAC‐ resistance, providing a new strategy for targeting CDK16 to enhance chemotherapy efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, NeoplasmBreast NeoplasmsCancer-Associated FibroblastsNeoplastic Stem CellsCyclin-Dependent KinasesHumansFemaleAnimalsMiceTumor MicroenvironmentCell Line, TumorSingle-Cell AnalysisGene Expression Regulation, NeoplasticCell Adhesion Molecules

Stichwörter der Autor:innen

CDK16+ luminal progenitor cell‐like tumor cellsPOSTN+ cancer‐associated fibroblastschemotherapy resistancesingle cell and spatial transcriptomicstumor microenvironment

Substanzen

Cyclin-Dependent KinasesPOSTN protein, humanCell Adhesion Molecules

Autor:innen und Institutionen

  • Shanghai Institute of Immunology, Center for Immune-Related Diseases Research at Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
  • Shanghai Jiao Tong University School of Medicine-Yale Institute for Immune Metabolism, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
  • Department of Hepatobiliary Surgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Anhui Province Key Laboratory of Hepatopancreatobiliary…
  • Department of Medical Oncology, Affiliated Hospital of Hebei University, Hebei Key Laboratory of Cancer Radiotherapy and Chemotherapy, Baoding, 071000, China.

ORCID-Profile: Xinyu Ding, Qi Wu, Yanhua Du, Meng-Meng Ji, Hua Yang, Qingsong Hu, Youqiong Ye

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Shanghai Municipality
  • Shanghai Jiao Tong University 2030 Initiative
  • Research Funds of Centre for Leading Medicine and Advanced Technologies of IHM

Zitieren

APA

Ding, X., Wu, Q., Du, Y., Ji, M. M., Yang, H., Hu, Q., & Ye, Y. (2025). CDK16 + Luminal Progenitor Cell‐Like Tumor Cells Interacted with POSTN + Cancer‐Associated Fibroblasts Associate with Chemo‐Resistance In Breast Cancer. Small Methods. https://doi.org/10.1002/smtd.202401192

Vancouver

Ding X, Wu Q, Du Y, Ji MM, Yang H, Hu Q, et al. CDK16 + Luminal Progenitor Cell‐Like Tumor Cells Interacted with POSTN + Cancer‐Associated Fibroblasts Associate with Chemo‐Resistance In Breast Cancer. Small Methods. 2025. doi:10.1002/smtd.202401192

BibTeX
@article{Ding2025,
  author = {Ding, Xinyu and Wu, Qi and Du, Yanhua and Ji, Meng-Meng and Yang, Hua and Hu, Qingsong and Ye, Youqiong},
  title = {CDK16 + Luminal Progenitor Cell‐Like Tumor Cells Interacted with POSTN + Cancer‐Associated Fibroblasts Associate with Chemo‐Resistance In Breast Cancer},
  journal = {Small Methods},
  year = {2025},
  doi = {10.1002/smtd.202401192}
}
Kostenlos starten →